A High-Throughput Small Molecule Screen Identifies Ouabain as Synergistic with miR-34a in Killing Lung Cancer Cells.

Rupaimoole, Rajesha; Yoon, Bohyung; Zhang, Wen Cai; Adams, Brian D; Slack, Frank J

Rupaimoole, Rajesha; Yoon, Bohyung; Zhang, Wen Cai; Adams, Brian D; Slack, Frank J.

Afiliación

Rupaimoole R; HMS Initiative for RNA Medicine and Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Yoon B; HMS Initiative for RNA Medicine and Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Zhang WC; HMS Initiative for RNA Medicine and Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Adams BD; HMS Initiative for RNA Medicine and Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Slack FJ; HMS Initiative for RNA Medicine and Department of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA. Electronic address: fslack@bidmc.harvard.edu.

iScience ; 23(2): 100878, 2020 Feb 21.

Article en En | MEDLINE | ID: mdl-32062455

Palabras clave

Biomolecules; Biotechnology; Cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: IScience Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google